Liver biopsy not required for hepatitis B medicine

24 October 2011

From 1 November 2011, people with hepatitis B will no longer have to undergo liver biopsy before they can receive hepatitis B medicine, and instead may opt for a liver function test.

Supporters of the change say the requirement had blocked many with hepatitis B virus (HBV) infection from accessing treatment, as they were either reluctant to have the invasive biopsy procedure or they lived in a remote area.

Pilot programs will also be rolled out next year offering GPs training to prescribe HBV medicine without needing to refer the person to a specialist.

Experts said the new approach would tackle Australia’s fastest increasing cause of cancer death, liver cancer from viral hepatitis.

Treatment rates for hepatitis C surged 50 per cent when a similar biopsy requirement was relaxed in 2006.

The Pharmaceutical Benefits Advisory Committee (PBAC) - the government committee that assesses applications for listing of medicines on the Pharmaceutical Benefits Scheme (PBS) - endorsed the change, which was jointly proposed by the Australian Society for HIV Medicine, Australian Liver Association and other stakeholders (online, Jul 2011).


 
Sponsored links

myDr Newsletter

Get myDr delivered to your inbox Privacy Policy
 
Advertisement
Advertisement
Advertisement

This web site is intended for Australian residents and is not a sbstitute for independent professional advice. Information and interactions contained in ths Web site are for infomation purposes only and are not intended ot be used to diagnose,treat , cure or prevent any disease.Further , the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. MIMS Australia Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incured by use of or relance on the information made available via or throught myDr whether arising from negligence or otherwise.
See Privacy Policy and Disclaimer.